, Tracking Stock Market Picks
Enter Symbol:

down 87.36 %

CELSION CORP (CLSN) rated Buy with price target $7 by Needham

Posted on: Wednesday,  Nov 11, 2009  8:25 AM ET by Needham

Needham rated Buy CELSION CORP (NASDAQ: CLSN) on 11/11/2009, when the stock price was $15.75. Since
then, CELSION CORP has lost 87.37% as of 01/19/2016's recent price of $1.99.
If you would have followed this Needham's recommendation on CLSN, you would have lost 87.36% of your investment in 2260 days.

Celsion Corporation (Celsion) is an oncology drug development company focused on developing drugs for the treatment of various cancer indications. The Company?s product ThermoDox is evaluated in a Phase III clinical trial for primary liver cancer and a Phase II study for recurrent chest wall breast cancer (RCW). ThermoDox is a liposomal encapsulation of doxorubicin, an oncology drug for the treatment of a range of cancers.

Needham & Company, LLC focuses on emerging growth companies in technology, biotechnology and life sciences. The firm's research goal is to service the needs of growth-oriented institutional clients. Needham & Company has established itself as a premier specialty investment bank providing timely and valuable analysis on companies that are under-covered by the majority of Wall Street firms.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/11/2009 8:25 AM Buy
15.75 31.50
as of 12/31/2009
1 Week down  -5.96 %
1 Month down  -8.38 %
3 Months down  -13.14 %
1 YTD down  -13.14 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy